BBOTVSEOCN• 28 Days (Normalized)
BBOT vs EOCN (BridgeBio Oncology Therapeutics Inc. vs Eocene Ltd.)
Showing Closing Date Range from Sep 11 to Oct 9, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.31
-33.13%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
EOCN Performance $3.54
+1.43%
Eocene Ltd.
Normalized Baseline0.00%
Alpha Spread Margin EOCN LEADS
-34.56 pts
EOCN outperforming by 34.56 percentage points
BBOTEOCN
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT EOCN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(21 dates)
| Date | BBOT Price | BBOT Gain (%) | EOCN Price | EOCN Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 09, 2026 | $3.31 | -33.13% | $3.54 | +1.43% | -34.56% |
| Oct 08, 2026 | $3.42 | -30.91% | $3.62 | +3.72% | -34.63% |
| Oct 07, 2026 | $3.44 | -30.51% | $3.46 | -0.92% | -29.59% |
| Oct 06, 2026 | $3.50 | -29.29% | $3.36 | -3.72% | -25.57% |
| Oct 05, 2026 | $3.60 | -27.27% | $3.45 | -1.15% | -26.12% |
| Oct 02, 2026 | $3.89 | -21.41% | $3.61 | +3.44% | -24.85% |
| Oct 01, 2026 | $- | $3.41 | -2.44% | - | |
| Sep 30, 2026 | $4.10 | -17.17% | $3.49 | +0.00% | -17.17% |
| Sep 29, 2026 | $3.92 | -20.81% | $- | - | |
| Sep 28, 2026 | $3.81 | -23.03% | $- | - | |
| Sep 25, 2026 | $3.95 | -20.20% | $- | - | |
| Sep 24, 2026 | $3.99 | -19.39% | $- | - | |
| Sep 23, 2026 | $4.16 | -15.96% | $- | - | |
| Sep 22, 2026 | $4.66 | -5.86% | $- | - | |
| Sep 21, 2026 | $4.66 | -5.86% | $- | - |
Page 1 of 2